Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
---|
02/01/2006 | EP1620130A1 Prodrugs cleavable by cd26 |
01/26/2006 | WO2005079747A8 Pharmaceutical preparation for the oral cavity |
01/26/2006 | US20060020110 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
01/25/2006 | EP1619201A1 Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith |
01/25/2006 | EP1617860A2 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
01/18/2006 | EP1616034A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
01/18/2006 | EP1615945A2 Glycopegylation methods and proteins/peptides produced by the methods |
01/12/2006 | WO2006004238A1 Process of purifying vancomycin hydrochloride |
01/11/2006 | EP1613958A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
01/05/2006 | US20060003938 Novel pyrrhocoricin-derived peptides and methods of use thereof |
01/05/2006 | US20060003406 Process of purifying vancomycin hydrochloride |
01/04/2006 | EP1612216A1 Process of purifying vancomycin hydrochloride |
12/29/2005 | US20050288221 Glycopeptide antibiotics |
12/29/2005 | US20050287641 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
12/28/2005 | EP1609796A1 N-glycoside type glycolipids and hollow fiber type organic nanotubes made of the same |
12/28/2005 | EP1608688A2 Branched water-soluble polymers and their conjugates |
12/28/2005 | EP1434779B1 Cross-linked glycopeptide-cephalosporin antibiotics |
12/27/2005 | US6979723 Preparing preferential glycoprotein; obtain chemical intermediate, expose to vancomycin, an amine and formaldehyde, recover glycopeptide |
12/27/2005 | US6979536 forming a triple stranded complex between the nucleic acid to be determined and two or more probe molecules |
12/22/2005 | US20050282770 Synthetic glycosulfopeptides and methods of synthesis thereof |
12/22/2005 | US20050282742 Such as bortezomib, by freeze drying |
12/22/2005 | US20050282741 Peptides and their use to ameliorate cell death |
12/15/2005 | WO2005118625A1 Triazole-linked glycoamino acids and glycopeptides |
12/15/2005 | WO2005056572A3 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
12/14/2005 | EP1603931A2 Methods of evaluating glycomolecules for enhanced activities |
12/13/2005 | US6974797 Bactericides for drug resistant bacteria |
12/08/2005 | WO2005116059A1 Method of producing highly pure teicoplanin |
12/07/2005 | EP1602663A1 Triazole-linked glycoamino acids and glycopeptides |
12/07/2005 | EP1601686A1 Protein-binding doxorubicin peptide derivatives |
12/01/2005 | US20050266526 Glycoprotein synthesis |
11/24/2005 | US20050261172 Peptide for increasing bone density; peptide is glycosylated, is 4 amino acids in length; the amino acid sequence consists of a sequence identical to the first 4 consecutive amino acids |
11/23/2005 | EP1597265A2 Glycosolated enkephalin agents |
11/17/2005 | WO2005108417A1 Polymeric primer for sugar peptide synthesis |
11/17/2005 | US20050255038 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
11/16/2005 | EP1594898A2 Glycosylated specificity exchangers |
11/15/2005 | US6964860 Culturing a glycopeptide antibiotic-producing strain of Streptomyces hygroscopicus under aerobic conditions and recovering the antibiotic; specific strains of microorganism; antibiotic is cyclic peptide with 2-iminoimidazolidine groups |
11/10/2005 | US20050250679 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
11/10/2005 | US20050250678 polypeptide (interferon, colony stimulating factor, human growth hormone) having an O-linked glycosylation site that does not exist in a wild type polypeptide; glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent or a biomolecule is covalently linked through the site |
11/10/2005 | US20050250677 Glycopeptide antibiotic derivatives |
11/08/2005 | US6962970 Glycopeptide derivatives and pharmaceutical compositions containing the same |
11/03/2005 | US20050245481 Method of producing teicoplanin |
11/02/2005 | EP1589994A2 Composition and method for preventing or treating a virus infection |
11/02/2005 | EP1254164B1 Selective n-acylation of a82846 glycopeptide analogs |
10/27/2005 | US20050239739 Conjugates and compositions for cellular delivery |
10/27/2005 | US20050239691 Cross-linked glycopeptide - cephalosporin antibiotics |
10/27/2005 | US20050239690 Intermediate for preparing glycopeptide derivatives |
10/27/2005 | US20050239689 Vancomycin analogs and methods thereof |
10/25/2005 | US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid |
10/20/2005 | WO2005097158A1 Amphipathic glycopeptides |
10/20/2005 | US20050233412 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine |
10/20/2005 | CA2560956A1 Amphipathic glycopeptides |
10/19/2005 | CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
10/19/2005 | CN1223378C Cyclodextrin containing glycopeptides antibiotic pharmaceutical compositions |
10/13/2005 | WO2005095331A1 Agent for binding sugar chain to peptide |
10/12/2005 | EP1419174A4 Process for preparing glycopeptide derivatives |
10/11/2005 | CA2333875C Redox reversible bipyridyl osmium complex conjugates |
10/11/2005 | CA2333732C Redox reversible imidazole-osmium complex conjugates |
10/06/2005 | US20050222382 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
10/06/2005 | US20050222012 Methods and compositions for treating leukemia |
10/05/2005 | CN1676023A Material and method for producing food |
10/04/2005 | US6951840 Peptidase inhibitor; bactericides |
09/29/2005 | WO2005090382A1 Antithrombotic compound |
09/29/2005 | CA2555036A1 Antithrombotic compound |
09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
09/27/2005 | US6949681 Intermediate for preparing glycopeptide derivatives |
09/22/2005 | WO2005016248A3 A novel antiproliferative factor and methods of use |
09/22/2005 | US20050209133 Glycoprotein synthesis |
09/22/2005 | US20050209132 Cross-linked glycopeptide-cephalosporin antibiotics |
09/21/2005 | EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
09/21/2005 | CN1671737A Export and modification of (poly)peptides in the lantibiotic way |
09/21/2005 | CN1671732A Process for purifying glycopeptide phospohonate derivatives |
09/15/2005 | WO2005085294A1 Hyaluronic acid/methotrexate compound |
09/15/2005 | WO2005042568A3 Hydrochloride salts of a glycopeptide phosphonate derivative |
09/15/2005 | US20050203003 Contulakin-G, analogs thereof and uses therefor |
09/15/2005 | CA2559188A1 Hyaluronic acid-methotrexate conjugate |
09/14/2005 | EP1574516A1 Antithrombotic compound |
09/07/2005 | CN1665832A Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
09/06/2005 | US6939947 administering glycoproteins as antibiotics for prophylaxis of bacterial infections; vancomycin derivatives; peptide antibiotics |
09/06/2005 | US6939945 Synthetic peptide for use as tool in human therapeutics and diagnostics |
09/01/2005 | WO2005079747A1 Pharmaceutical preparation for the oral cavity |
08/31/2005 | EP1567169A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
08/25/2005 | US20050186657 Glycoprotein synthesis |
08/25/2005 | US20050186656 Glycoprotein synthesis |
08/18/2005 | WO2005044197A3 Synthesis of glycopeptides with superior pharmacokinetic properties |
08/18/2005 | US20050181471 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
08/17/2005 | EP1461445A4 Glycoprotein remodeling using endoglycanases |
08/17/2005 | EP0760671B1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
08/11/2005 | WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same |
08/11/2005 | US20050175602 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide |
08/09/2005 | US6927042 Glycoprotein synthesis |
08/09/2005 | US6926408 Continuous two-dimensional corneal topography target |
08/04/2005 | WO2005070138A2 O-linked glycosylation of peptides |
08/04/2005 | US20050171010 vancomycin derivative multibinding agents comprising ligands covalently connected, capable of binding to a transglycosylase enzyme substrate |
08/04/2005 | CA2552892A1 O-linked glycosylation of peptides |
08/03/2005 | EP1558747A2 Glycoprotein synthesis |
07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
07/28/2005 | US20050164919 Bactericides; peptide antibiotics |
07/28/2005 | US20050164916 Glycopeptide phosphonate derivatives |